JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Sign up to stay informed--receive email notifications for this journal
Editor-in-Chief: Leonard S. Sender, MD
ISSN: 2156-5333 • Published Quarterly • Online ISSN: 2156-535X
The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.
You may be interested in the following publications:
The leading interdisciplinary journal reporting on the clinical, educational, legal, and ethical aspects of palliative care for patients in end of life or with intractable pain, focusing on improving quality of life.
The established journal with over 25 years of peer-reviewed papers on new and innovative investigations of methods to improve cancer therapy. The Journal focuses on advancements in radioimmunotherapy and radiopharmaceuticals.
formerly Hybridoma
The essential journal for scientists and clinicians in the fields of molecular immunology and immunopathology, and for all those applying molecular immunological methods for experimental and therapeutic purposes.
Presents the latest findings and reviews of research covering IFNs and cytokines, their relevance to chronic and acute disease, studies involving cytokine biology, mechanisms of IFN action, and their role in virus infection.
Browse All Publications »